Clinical Trials Browser

Phase 2/3 × Completed × Temozolomide × Clear all

NCT04396860 2026-03-05

Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma

Phase 2/3 Completed

159 enrolled 17 charts

Gliosarcoma

NCT01236560 2024-02-20

Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma

Phase 2/3 Completed

101 enrolled 15 charts

Astrocytoma, Spinal Cord Neoplasms

NCT02678975 2021-03-18

Disulfiram in Recurrent Glioblastoma

Phase 2/3 Completed

Glioblastoma, Glioma

NCT00749723 2018-07-20

HIT-REZ-2005

Phase 2/3 Completed

Brain Neoplasms, Ependymoma, Medulloblastoma, Recurrence